Cold and Flu Supplement Market, Global Outlook and Forecast 2022-2028

March 2022 | 65 pages | ID: CF317CF354E4EN
Market Monitor Global

Abstracts

Demand for cold and flu supplements has been increasing among the consumers in order to boost immunity and prevent the occurrences of such diseases. Cold and flu supplements are primarily consumed to enhance the immunity system of the individual. Cold and flu supplements are available in different forms, among them tablet and capsule are the most popular forms.

This report contains market size and forecasts of Cold and Flu Supplement in Global, including the following market information:

Global Cold and Flu Supplement Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Cold and Flu Supplement market was valued at 15600 million in 2021 and is projected to reach US$ 21270 million by 2028, at a CAGR of 4.5% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Natural Molecules Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cold and Flu Supplement include Wakunaga of America, Neurobiologix, The Vitamin Shoppe, Klaire Labs, Nordic Naturals, Himalaya Global Holdings, Dr. Willmar Schwabe GmbH, FineVine and Flora, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cold and Flu Supplement companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cold and Flu Supplement Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Cold and Flu Supplement Market Segment Percentages, by Type, 2021 (%)

• Natural Molecules
• Herbal Extracts
• Vitamins and Minerals
• Others

Global Cold and Flu Supplement Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Cold and Flu Supplement Market Segment Percentages, by Application, 2021 (%)

• Online
• Offline

Global Cold and Flu Supplement Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Cold and Flu Supplement Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Cold and Flu Supplement revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Cold and Flu Supplement revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Wakunaga of America
• Neurobiologix
• The Vitamin Shoppe
• Klaire Labs
• Nordic Naturals
• Himalaya Global Holdings
• Dr. Willmar Schwabe GmbH
• FineVine
• Flora
• Pfizer
• GlaxoSmithKline
• NOW Foods

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Cold and Flu Supplement Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Cold and Flu Supplement Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL COLD AND FLU SUPPLEMENT OVERALL MARKET SIZE

2.1 Global Cold and Flu Supplement Market Size: 2021 VS 2028
2.2 Global Cold and Flu Supplement Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Cold and Flu Supplement Players in Global Market
3.2 Top Global Cold and Flu Supplement Companies Ranked by Revenue
3.3 Global Cold and Flu Supplement Revenue by Companies
3.4 Top 3 and Top 5 Cold and Flu Supplement Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cold and Flu Supplement Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cold and Flu Supplement Players in Global Market
  3.6.1 List of Global Tier 1 Cold and Flu Supplement Companies
  3.6.2 List of Global Tier 2 and Tier 3 Cold and Flu Supplement Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Cold and Flu Supplement Market Size Markets, 2021 & 2028
  4.1.2 Natural Molecules
  4.1.3 Herbal Extracts
  4.1.4 Vitamins and Minerals
  4.1.5 Others
4.2 By Type - Global Cold and Flu Supplement Revenue & Forecasts
  4.2.1 By Type - Global Cold and Flu Supplement Revenue, 2017-2022
  4.2.2 By Type - Global Cold and Flu Supplement Revenue, 2023-2028
  4.2.3 By Type - Global Cold and Flu Supplement Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Cold and Flu Supplement Market Size, 2021 & 2028
  5.1.2 Online
  5.1.3 Offline
5.2 By Application - Global Cold and Flu Supplement Revenue & Forecasts
  5.2.1 By Application - Global Cold and Flu Supplement Revenue, 2017-2022
  5.2.2 By Application - Global Cold and Flu Supplement Revenue, 2023-2028
  5.2.3 By Application - Global Cold and Flu Supplement Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Cold and Flu Supplement Market Size, 2021 & 2028
6.2 By Region - Global Cold and Flu Supplement Revenue & Forecasts
  6.2.1 By Region - Global Cold and Flu Supplement Revenue, 2017-2022
  6.2.2 By Region - Global Cold and Flu Supplement Revenue, 2023-2028
  6.2.3 By Region - Global Cold and Flu Supplement Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Cold and Flu Supplement Revenue, 2017-2028
  6.3.2 US Cold and Flu Supplement Market Size, 2017-2028
  6.3.3 Canada Cold and Flu Supplement Market Size, 2017-2028
  6.3.4 Mexico Cold and Flu Supplement Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Cold and Flu Supplement Revenue, 2017-2028
  6.4.2 Germany Cold and Flu Supplement Market Size, 2017-2028
  6.4.3 France Cold and Flu Supplement Market Size, 2017-2028
  6.4.4 U.K. Cold and Flu Supplement Market Size, 2017-2028
  6.4.5 Italy Cold and Flu Supplement Market Size, 2017-2028
  6.4.6 Russia Cold and Flu Supplement Market Size, 2017-2028
  6.4.7 Nordic Countries Cold and Flu Supplement Market Size, 2017-2028
  6.4.8 Benelux Cold and Flu Supplement Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Cold and Flu Supplement Revenue, 2017-2028
  6.5.2 China Cold and Flu Supplement Market Size, 2017-2028
  6.5.3 Japan Cold and Flu Supplement Market Size, 2017-2028
  6.5.4 South Korea Cold and Flu Supplement Market Size, 2017-2028
  6.5.5 Southeast Asia Cold and Flu Supplement Market Size, 2017-2028
  6.5.6 India Cold and Flu Supplement Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Cold and Flu Supplement Revenue, 2017-2028
  6.6.2 Brazil Cold and Flu Supplement Market Size, 2017-2028
  6.6.3 Argentina Cold and Flu Supplement Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Cold and Flu Supplement Revenue, 2017-2028
  6.7.2 Turkey Cold and Flu Supplement Market Size, 2017-2028
  6.7.3 Israel Cold and Flu Supplement Market Size, 2017-2028
  6.7.4 Saudi Arabia Cold and Flu Supplement Market Size, 2017-2028
  6.7.5 UAE Cold and Flu Supplement Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Wakunaga of America
  7.1.1 Wakunaga of America Corporate Summary
  7.1.2 Wakunaga of America Business Overview
  7.1.3 Wakunaga of America Cold and Flu Supplement Major Product Offerings
  7.1.4 Wakunaga of America Cold and Flu Supplement Revenue in Global Market (2017-2022)
  7.1.5 Wakunaga of America Key News
7.2 Neurobiologix
  7.2.1 Neurobiologix Corporate Summary
  7.2.2 Neurobiologix Business Overview
  7.2.3 Neurobiologix Cold and Flu Supplement Major Product Offerings
  7.2.4 Neurobiologix Cold and Flu Supplement Revenue in Global Market (2017-2022)
  7.2.5 Neurobiologix Key News
7.3 The Vitamin Shoppe
  7.3.1 The Vitamin Shoppe Corporate Summary
  7.3.2 The Vitamin Shoppe Business Overview
  7.3.3 The Vitamin Shoppe Cold and Flu Supplement Major Product Offerings
  7.3.4 The Vitamin Shoppe Cold and Flu Supplement Revenue in Global Market (2017-2022)
  7.3.5 The Vitamin Shoppe Key News
7.4 Klaire Labs
  7.4.1 Klaire Labs Corporate Summary
  7.4.2 Klaire Labs Business Overview
  7.4.3 Klaire Labs Cold and Flu Supplement Major Product Offerings
  7.4.4 Klaire Labs Cold and Flu Supplement Revenue in Global Market (2017-2022)
  7.4.5 Klaire Labs Key News
7.5 Nordic Naturals
  7.5.1 Nordic Naturals Corporate Summary
  7.5.2 Nordic Naturals Business Overview
  7.5.3 Nordic Naturals Cold and Flu Supplement Major Product Offerings
  7.5.4 Nordic Naturals Cold and Flu Supplement Revenue in Global Market (2017-2022)
  7.5.5 Nordic Naturals Key News
7.6 Himalaya Global Holdings
  7.6.1 Himalaya Global Holdings Corporate Summary
  7.6.2 Himalaya Global Holdings Business Overview
  7.6.3 Himalaya Global Holdings Cold and Flu Supplement Major Product Offerings
  7.6.4 Himalaya Global Holdings Cold and Flu Supplement Revenue in Global Market (2017-2022)
  7.6.5 Himalaya Global Holdings Key News
7.7 Dr. Willmar Schwabe GmbH
  7.7.1 Dr. Willmar Schwabe GmbH Corporate Summary
  7.7.2 Dr. Willmar Schwabe GmbH Business Overview
  7.7.3 Dr. Willmar Schwabe GmbH Cold and Flu Supplement Major Product Offerings
  7.7.4 Dr. Willmar Schwabe GmbH Cold and Flu Supplement Revenue in Global Market (2017-2022)
  7.7.5 Dr. Willmar Schwabe GmbH Key News
7.8 FineVine
  7.8.1 FineVine Corporate Summary
  7.8.2 FineVine Business Overview
  7.8.3 FineVine Cold and Flu Supplement Major Product Offerings
  7.8.4 FineVine Cold and Flu Supplement Revenue in Global Market (2017-2022)
  7.8.5 FineVine Key News
7.9 Flora
  7.9.1 Flora Corporate Summary
  7.9.2 Flora Business Overview
  7.9.3 Flora Cold and Flu Supplement Major Product Offerings
  7.9.4 Flora Cold and Flu Supplement Revenue in Global Market (2017-2022)
  7.9.5 Flora Key News
7.10 Pfizer
  7.10.1 Pfizer Corporate Summary
  7.10.2 Pfizer Business Overview
  7.10.3 Pfizer Cold and Flu Supplement Major Product Offerings
  7.10.4 Pfizer Cold and Flu Supplement Revenue in Global Market (2017-2022)
  7.10.5 Pfizer Key News
7.11 GlaxoSmithKline
  7.11.1 GlaxoSmithKline Corporate Summary
  7.11.2 GlaxoSmithKline Business Overview
  7.11.3 GlaxoSmithKline Cold and Flu Supplement Major Product Offerings
  7.11.4 GlaxoSmithKline Cold and Flu Supplement Revenue in Global Market (2017-2022)
  7.11.5 GlaxoSmithKline Key News
7.12 NOW Foods
  7.12.1 NOW Foods Corporate Summary
  7.12.2 NOW Foods Business Overview
  7.12.3 NOW Foods Cold and Flu Supplement Major Product Offerings
  7.12.4 NOW Foods Cold and Flu Supplement Revenue in Global Market (2017-2022)
  7.12.5 NOW Foods Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Cold and Flu Supplement Market Opportunities & Trends in Global Market
Table 2. Cold and Flu Supplement Market Drivers in Global Market
Table 3. Cold and Flu Supplement Market Restraints in Global Market
Table 4. Key Players of Cold and Flu Supplement in Global Market
Table 5. Top Cold and Flu Supplement Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cold and Flu Supplement Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cold and Flu Supplement Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cold and Flu Supplement Product Type
Table 9. List of Global Tier 1 Cold and Flu Supplement Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cold and Flu Supplement Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cold and Flu Supplement Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cold and Flu Supplement Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cold and Flu Supplement Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Cold and Flu Supplement Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cold and Flu Supplement Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cold and Flu Supplement Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Cold and Flu Supplement Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cold and Flu Supplement Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cold and Flu Supplement Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cold and Flu Supplement Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cold and Flu Supplement Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cold and Flu Supplement Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cold and Flu Supplement Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cold and Flu Supplement Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cold and Flu Supplement Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cold and Flu Supplement Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cold and Flu Supplement Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cold and Flu Supplement Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cold and Flu Supplement Revenue, (US$, Mn), 2023-2028
Table 30. Wakunaga of America Corporate Summary
Table 31. Wakunaga of America Cold and Flu Supplement Product Offerings
Table 32. Wakunaga of America Cold and Flu Supplement Revenue (US$, Mn), (2017-2022)
Table 33. Neurobiologix Corporate Summary
Table 34. Neurobiologix Cold and Flu Supplement Product Offerings
Table 35. Neurobiologix Cold and Flu Supplement Revenue (US$, Mn), (2017-2022)
Table 36. The Vitamin Shoppe Corporate Summary
Table 37. The Vitamin Shoppe Cold and Flu Supplement Product Offerings
Table 38. The Vitamin Shoppe Cold and Flu Supplement Revenue (US$, Mn), (2017-2022)
Table 39. Klaire Labs Corporate Summary
Table 40. Klaire Labs Cold and Flu Supplement Product Offerings
Table 41. Klaire Labs Cold and Flu Supplement Revenue (US$, Mn), (2017-2022)
Table 42. Nordic Naturals Corporate Summary
Table 43. Nordic Naturals Cold and Flu Supplement Product Offerings
Table 44. Nordic Naturals Cold and Flu Supplement Revenue (US$, Mn), (2017-2022)
Table 45. Himalaya Global Holdings Corporate Summary
Table 46. Himalaya Global Holdings Cold and Flu Supplement Product Offerings
Table 47. Himalaya Global Holdings Cold and Flu Supplement Revenue (US$, Mn), (2017-2022)
Table 48. Dr. Willmar Schwabe GmbH Corporate Summary
Table 49. Dr. Willmar Schwabe GmbH Cold and Flu Supplement Product Offerings
Table 50. Dr. Willmar Schwabe GmbH Cold and Flu Supplement Revenue (US$, Mn), (2017-2022)
Table 51. FineVine Corporate Summary
Table 52. FineVine Cold and Flu Supplement Product Offerings
Table 53. FineVine Cold and Flu Supplement Revenue (US$, Mn), (2017-2022)
Table 54. Flora Corporate Summary
Table 55. Flora Cold and Flu Supplement Product Offerings
Table 56. Flora Cold and Flu Supplement Revenue (US$, Mn), (2017-2022)
Table 57. Pfizer Corporate Summary
Table 58. Pfizer Cold and Flu Supplement Product Offerings
Table 59. Pfizer Cold and Flu Supplement Revenue (US$, Mn), (2017-2022)
Table 60. GlaxoSmithKline Corporate Summary
Table 61. GlaxoSmithKline Cold and Flu Supplement Product Offerings
Table 62. GlaxoSmithKline Cold and Flu Supplement Revenue (US$, Mn), (2017-2022)
Table 63. NOW Foods Corporate Summary
Table 64. NOW Foods Cold and Flu Supplement Product Offerings
Table 65. NOW Foods Cold and Flu Supplement Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Cold and Flu Supplement Segment by Type in 2021
Figure 2. Cold and Flu Supplement Segment by Application in 2021
Figure 3. Global Cold and Flu Supplement Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cold and Flu Supplement Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cold and Flu Supplement Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cold and Flu Supplement Revenue in 2021
Figure 8. By Type - Global Cold and Flu Supplement Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cold and Flu Supplement Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cold and Flu Supplement Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cold and Flu Supplement Revenue Market Share, 2017-2028
Figure 12. US Cold and Flu Supplement Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cold and Flu Supplement Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cold and Flu Supplement Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cold and Flu Supplement Revenue Market Share, 2017-2028
Figure 16. Germany Cold and Flu Supplement Revenue, (US$, Mn), 2017-2028
Figure 17. France Cold and Flu Supplement Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cold and Flu Supplement Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cold and Flu Supplement Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cold and Flu Supplement Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cold and Flu Supplement Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cold and Flu Supplement Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cold and Flu Supplement Revenue Market Share, 2017-2028
Figure 24. China Cold and Flu Supplement Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cold and Flu Supplement Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cold and Flu Supplement Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cold and Flu Supplement Revenue, (US$, Mn), 2017-2028
Figure 28. India Cold and Flu Supplement Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cold and Flu Supplement Revenue Market Share, 2017-2028
Figure 30. Brazil Cold and Flu Supplement Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cold and Flu Supplement Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cold and Flu Supplement Revenue Market Share, 2017-2028
Figure 33. Turkey Cold and Flu Supplement Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cold and Flu Supplement Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cold and Flu Supplement Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cold and Flu Supplement Revenue, (US$, Mn), 2017-2028
Figure 37. Wakunaga of America Cold and Flu Supplement Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Neurobiologix Cold and Flu Supplement Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. The Vitamin Shoppe Cold and Flu Supplement Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Klaire Labs Cold and Flu Supplement Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Nordic Naturals Cold and Flu Supplement Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Himalaya Global Holdings Cold and Flu Supplement Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Dr. Willmar Schwabe GmbH Cold and Flu Supplement Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. FineVine Cold and Flu Supplement Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Flora Cold and Flu Supplement Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Pfizer Cold and Flu Supplement Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. GlaxoSmithKline Cold and Flu Supplement Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. NOW Foods Cold and Flu Supplement Revenue Year Over Year Growth (US$, Mn) & (2017-2022)